No changes were seen in the low-dose group (gray bars)
Another retrospective study (2023) focusing on dulaglutide in T2D reported lower incidence of new-onset moderate-to-severe ED in the group on dulaglutide over 12 years compared to those not on it
Formulated for targeted blemish control, it helps diminish dark spots, acne marks, and signs of premature aging while promoting a significantly fairer, radiant complexion
Likewise, the results of another study indicated the Ca, Ph, Mg, Fe, and K [34]
However, some studies have highlighted melanotan II's potential involvement in melanoma, the deadliest form of skin cancer, although the research so far is inconclusive
This structural advantage gives tesamorelin a longer duration of action and a more potent GH response